Researchers used gene therapy to convert harmful fatty acids into beneficial ones to help combat childhood obesity.

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for ...

Illumina unveiled its MiSeq i100 Series of sequencing systems: two new benchtop instruments, MiSeq i100 and MiSeq i100 Plus ...

Single-atom editing under mild conditions was achieved for heterocyclics, thanks to a new oxygen-to-nitrogen photocatalyst.

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...

Among the newer initiatives was developing the lab of the future; next-gen biology; AI and sustainability. The new facility ...

Findings implied more generally that the effects of dietary restriction on health and lifespan may be partially ...

The company claims to have decoded human cell rejuvenation and identified potential gene targets for therapies that treat ...

The company reflects on their latest IND approval, the evolution of their end-to-end drug discovery platform, and what’s next ...

The combined company—which will carry the Vizgen name—will build upon its namesake predecessor’s expertise in single-cell ...

Scientists used stem cells to recreate the growth of Lewy bodies in human neurons to gain insight into why and how they form.